TANGEN BIOSCIENCES, INC.

Profile

Company Names

TANGEN BIOSCIENCES, INC.

Addresses

20 COMMERCIAL STREET, BRANFORD, CT 06405

780 EAST MAIN ST., SUITE 1, BRANFORD, CT 06405

780 EAST MAIN STREET, SUITE 1, BRANFORD, CT 06405

Phone Numbers

203-433-4045

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$20,424,747.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-05-26 
$464,767.00 
$2,500,000.00 
$2,035,233.00 
Debt 
3
2020-06-19 
$11,239,731.00 
$20,000,000.00 
$8,760,269.00 
Equity, Debt 
2
2019-03-14 
$6,689,846.00 
$11,069,342.00 
$4,379,496.00 
Equity 
1
2015-12-14 
$2,030,403.00 
$3,030,403.00 
$1,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPHER 
 
BENOIT 
DIRECTOR
ENZYMATICS INC   |  TWINSTRAND BIOSCIENCES, INC.   |  TANGEN BIOSCIENCES, INC.   |  CANAL BIOSCIENCES, INC.
RICHARD 
 
BIRKMEYER, PHD 
EXECUTIVE OFFICER, DIRECTOR
TANGEN BIOSCIENCES, INC.
RICHARD 
C. 
BIRKMEYER, PHD 
EXECUTIVE OFFICER, DIRECTOR
TANGEN BIOSCIENCES, INC.
BRIAN 
 
CHIRICO 
EXECUTIVE OFFICER
TANGEN BIOSCIENCES, INC.
JOHN 
 
DAVIDSON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RADIO TIME INC.   |  FIRST AMERICAN BANCORP   |  PARMENTER REALTY FUND V, L.P.   |  JGF ENTERPRISES, LLC   |  TANGEN BIOSCIENCES, INC.   |  LIBERTY ONE LITHIUM CORP   |  ANB CORP (TX)
VANCE 
V. 
KERSHNER 
DIRECTOR
TANGEN BIOSCIENCES, INC.
ALAN 
 
LEVIN 
DIRECTOR
NATIONAL HOLDINGS CORP   |  DIFFUSION PHARMACEUTICALS LLC   |  TANGEN BIOSCIENCES, INC.
CHRISTOPHER 
 
MCLEOD 
DIRECTOR
ANCERA, INC.   |  TANGEN BIOSCIENCES, INC.   |  LANIER BIOTHERAPEUTICS, INC.   |  ENRICH THERAPEUTICS INC.   |  ENRICH BIOSYSTEMS INC.
JOHN 
RICHARD 
NOBILE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TANGEN BIOSCIENCES, INC.
DAN 
 
WAGNER 
DIRECTOR
MYCARE, INC.   |  SAMI HEALTH, INC.   |  EPIEP, INC.   |  TANGEN BIOSCIENCES, INC.   |  CIVIS ANALYTICS, INC.   |  OTOLITH SOUND, INC.
DANIEL 
 
WAGNER 
DIRECTOR
INNOVATIENT SOLUTIONS, INC.   |  REMOTEREALITY CORP   |  NEW HAVEN PHARMACEUTICALS, INC.   |  CMDBIOSCIENCE,INC.   |  SOFT TISSUE REGENERATION, INC.   |  ISOPLEXIS CORP   |  BARPAY, LLC   |  CORNOVUS PHARMACEUTICALS INC.   |  BIOREZ, INC.   |  AZITRA INC   |  ALLOMEK THERAPEUTICS, LLC   |  PROTEOWISE INC.   |  HASTE, INC.   |  TANGEN BIOSCIENCES, INC.   |  MITOTHERAPEUTIX, LLC   |  INTUS BIOSCIENCES, LLC   |  REZOLVE AI PLC   |  ENRICH BIOSYSTEMS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-05-26 
2020-07-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-06-19 
2019-03-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-14 
2015-12-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#